India’s Glenmark Establishes Unit In Romania
This article was originally published in PharmAsia News
Executive Summary
India's Glenmark Pharmaceuticals has established a new unit in Romania to produce specialty drugs. Glenmark sees a $50 million market in Romania within the next five years. Romania recently was admitted into the European Union and becomes the third European country to see a Glenmark unit established. (Click here for more